Drug intelligence / Profile preview

AG1000

Development stage
Preclinical
Lead developer
Insud Pharma
Modality
Small Molecules
Administration
Transdermal
01

Overview

AG1000 is a transdermal contraceptive patch under development by Agile Therapeutics that delivers levonorgestrel only, designed specifically for women who are breastfeeding or who cannot use estrogen-containing contraceptives. It is intended to provide long-acting reversible contraception via sustained systemic exposure to the progestin levonorgestrel, which primarily prevents pregnancy by inhibiting ovulation, thickening cervical mucus to block sperm penetration, and altering the endometrium to reduce the likelihood of implantation. AG1000 is positioned as a progestin-only, estrogen-free alternative to combined hormonal patches, leveraging Agile’s patch technology to maintain consistent hormone levels while avoiding estrogen-related risks.[13]

02

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on AG1000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AG1000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call